BiomX Inc. logo

BiomX Inc.

PHGE

AMEXIndustrialsAerospace & Defense

Previous close

$0.1375

−$0.0022 · -1.57%

Aug 21, 4:00 PM ET

PHGE company overview

Historical prices · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

25

Expensive

Momentum

25

Weakening

Sentiment

44

Mixed

Risk resilience

29

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

Industry
Aerospace & Defense
Sector
Industrials
Headquarters
US
CEO
Michael Oster
Listed since
Mar 13, 2019
Employees
20

Market position

Day range

Current $0.1375

52-week range

Current $0.1375

Open
$0.134
Previous close
$0.1397
Volume
898.06K
0.15× average
Average volume
5.87M
Average daily volume
Market cap
1.4M USD
Beta
1.37
Market reference 1
50-day average
$0.2725
-49.53% below average
200-day average
$2.6954
-94.90% below average

Financials

Financial statements

Income trends

Operating income

−32.91M USD+15.67%

Net income

−36.2M USD-104.20%
Income trends across reported periods−15.6M USD−24.12M USD−32.64M USD−41.16M USDOperating income, FY2021: −35.46M USDOperating income, FY2022: −27.22M USDOperating income, FY2023: −27.69M USDOperating income, FY2024: −39.03M USDOperating income, FY2025: −32.91M USDNet income, FY2021: −36.23M USDNet income, FY2022: −28.32M USDNet income, FY2023: −26.17M USDNet income, FY2024: −17.73M USDNet income, FY2025: −36.2M USDFY2021FY2022FY2023FY2024FY2025
Operating income FY2021 −35.46M USD. Operating income FY2022 −27.22M USD. Operating income FY2023 −27.69M USD. Operating income FY2024 −39.03M USD. Operating income FY2025 −32.91M USD. Net income FY2021 −36.23M USD. Net income FY2022 −28.32M USD. Net income FY2023 −26.17M USD. Net income FY2024 −17.73M USD. Net income FY2025 −36.2M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Cost of goods sold2.92M USD1.8M USD871K USD
Gross profit−2.92M USD−1.8M USD−871K USD
Research and development23.28M USD24.66M USD19.04M USD16.24M USD22.68M USD
Selling, general, and administrative6.71M USD11.78M USD7.78M USD9.46M USD11.27M USD
Operating expenses29.99M USD37.22M USD26.81M USD27.22M USD35.46M USD
Interest income460K USD1.05M USD1.12M USD902K USD2K USD
Interest expense984K USD2.79M USD2.4M USD2.07M USD699K USD
Depreciation and amortization2.92M USD1.8M USD871K USD2.52M USD2.57M USD
Operating income−32.91M USD−39.03M USD−27.69M USD−27.22M USD−35.46M USD
Net income−36.2M USD−17.73M USD−26.17M USD−28.32M USD−36.23M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
67%
6 beats, 3 misses, 0 met estimates
Average EPS surprise
+7.08%
9 comparable reports
Latest EPS result
-0.37

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.31-11.49-22.67-33.85Q4 '24MissQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26No estimateQ3 '26No estimate
Q4 2024, reported Nov 14, 2024: actual -18.44, estimate -11.41, surprise -61.61%, Miss. Q1 2025, reported Mar 25, 2025: actual -20.34, estimate -31.37, surprise +35.16%, Beat. Q2 2025, reported May 15, 2025: actual -6.27, estimate -7.98, surprise +21.43%, Beat. Q3 2025, reported Aug 13, 2025: actual -3.61, estimate -6.27, surprise +42.42%, Beat. Q4 2025, reported Nov 12, 2025: actual -5.51, estimate -5.61, surprise +1.69%, Beat. Q1 2026, reported Mar 24, 2026: actual -6.76, estimate -4.61, surprise -46.64%, Miss. Q2 2026, reported May 21, 2026: actual -7.38, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 19, 2026: actual -0.37, estimate —, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$38.00

27536.36% upside
Past 12 months12-month forecastHigh $38.00Average $38.00Low $38.00

Rating distribution

5 ratings
Strong buy00%
Buy480%
Hold120%
Sell00%
Strong sell00%

PHGE peers

Continue in GoAI

Research PHGE

research.disclaimer